Sage Journals: Discover world-class research

Abstract

Background:

Leptomeningeal contrast enhancement (LM CE) has been recently described in multiple sclerosis (MS) patients as a potential in vivo marker of cortical pathology.

Objectives:

To investigate the association of LM CE and development of cortical atrophy in 50 MS patients (27 relapsing-remitting (RR) and 23 secondary-progressive (SP)) followed for 5 years.

Methods:

The presence and number of LM CE foci were assessed only at the 5-year follow-up using three-dimensional (3D) fluid-attenuated inversion recovery magnetic resonance imaging (MRI) sequence obtained 10 minutes after single dose of gadolinium injection on 3T scanner. The percentage change in whole brain, cortical and deep gray matter (GM) volumes, and lesion volume (LV) was measured between baseline and the 5-year follow-up.

Results:

In total, 25 (50%) of MS patients had LM CE at the 5-year follow-up. Significantly more SPMS patients (12, 85.7%) had multiple LM CE foci, compared to those with RRMS (2, 18.2%) (p = 0.001). MS patients with LM CE showed significantly greater percentage decrease in total GM (−3.6% vs −2%, d = 0.80, p = 0.006) and cortical (−3.4% vs −1.8%, d = 0.84, p = 0.007) volumes and greater percentage increase in ventricular cerebrospinal fluid (vCSF) volume (22.8% vs 9.9%, d = 0.90, p = 0.003) over the follow-up, compared to those without.

Conclusion:

In this retrospective, pilot, observational longitudinal study, the presence of LM CE was associated with progression of cortical atrophy over 5 years.

Keywords

Multiple sclerosis leptomeningeal contrast enhancement cortical atrophy disability black holes

Get full access to this article

View all access options for this article.

References

Kutzelnigg

Lucchinetti

Stadelmann

et al . Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705–2712.

Lucchinetti

Popescu

Bunyan

et al . Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 2011; 365: 2188–2197.

Popescu

Lucchinetti

. Meningeal and cortical grey matter pathology in multiple sclerosis. BMC Neurol 2012; 12: 11.

Magliozzi

Howell

Vora

et al . Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007; 130: 1089–1104.

Magliozzi

Howell

Reeves

et al . A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 2010; 68: 477–493.

Serafini

Rosicarelli

Magliozzi

et al . Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 2004; 14: 164–174.

Choi

Howell

Carassiti

et al . Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. Brain 2012; 135: 2925–2937.

Howell

Reeves

Nicholas

et al . Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 2011; 134: 2755–2771.

Demaerel

Robberecht

Casteels

et al . Focal leptomeningeal MR enhancement along the chiasm as a presenting sign of multiple sclerosis. J Comput Assist Tomogr 1995; 19: 297–298.

10.

Absinta

Vuolo

Rao

et al . Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis. Neurology 2015; 85: 18–28.

11.

Barkhof

Reich

. Can leptomeningeal enhancement be linked to multiple sclerosis? Neurology 2015; 84: 762–763.

12.

Eisele

Griebe

Szabo

et al . Investigation of leptomeningeal enhancement in MS: A postcontrast FLAIR MRI study. Neurology 2015; 84: 770–775.

13.

Zivadinov

Cerza

Hagemeier

et al . Humoral response to EBV is associated with cortical atrophy and lesion burden in patients with MS. Neurol Neuroimmunol Neuroinflamm 2016; 3: e190.

14.

Kappus

Weinstock-Guttman

Hagemeier

et al . Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 2016; 87: 181–187.

15.

Zivadinov

Marr

Cutter

et al . Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS. Neurology 2011; 77: 138–144.

16.

Polak

Magnano

Zivadinov

et al . 3D FLAIRED: 3D fluid attenuated inversion recovery for enhanced detection of lesions in multiple sclerosis. Magn Reson Med 2012; 68: 874–881.

17.

Smith

Zhang

Jenkinson

et al . Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002; 17: 479–489.

18.

Dwyer

Bergsland

Zivadinov

. Improved longitudinal gray and white matter atrophy assessment via application of a 4-dimensional hidden Markov random field model. Neuroimage 2014; 90: 207–217.

19.

Patenaude

Smith

Kennedy

et al . A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011; 56: 907–922.

20.

Zivadinov

Heininen-Brown

Schirda

et al . Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: A case-control study. Neuroimage 2012; 59: 331–339.

21.

Zivadinov

Uher

Hagemeier

et al . A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients. Mult Scler 2016; 22: 1709–1718.

22.

Busse

Hariharan

et al . Fast spin echo sequences with very long echo trains: Design of variable refocusing flip angle schedules and generation of clinical T2 contrast. Magn Reson Med 2006; 55: 1030–1037.

23.

Calabrese

Agosta

Rinaldi

et al . Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009; 66: 1144–1150.

24.

Geurts

Pouwels

et al . Cortical lesions in multiple sclerosis: Combined postmortem MR imaging and histopathology. Am J Neuroradiol 2005; 26: 572–577.

25.

Walker

Huttner

O’Connor

. Cortical injury in multiple sclerosis: The role of the immune system. BMC Neurol 2011; 11: 152.

26.

Geurts

Pouwels

Uitdehaag

et al . Intracortical lesions in multiple sclerosis: Improved detection with 3D double inversion-recovery MR imaging. Radiology 2005; 236: 254–260.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.86 MB

0.00 MB

0.13 MB

0.41 MB

0.11 MB

0.09 MB

0.16 MB

0.41 MB

0.11 MB

0.09 MB

0.16 MB

Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective,pilot,observational longitudinal study

Abstract

Background:

Objectives:

Methods:

Results:

Conclusion:

Keywords

Get full access to this article

References

Supplementary Material